NCT03579693View on ClinicalTrials.gov

Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 14, 2018

Primary Completion Date

April 26, 2021

Study Completion Date

April 26, 2021

Conditions
Chronic Kidney DiseaseSarcopeniaFrailty
Interventions
DIETARY_SUPPLEMENT

CoQ10

CoQ10 tablet

DIETARY_SUPPLEMENT

Nicotinamide riboside

NR tablet

DIETARY_SUPPLEMENT

Placebo

Sugar pill designed to mimic coQ10 and NR

Trial Locations (1)

98104

University of Washington, Seattle

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Washington

OTHER

NCT03579693 - Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease | Biotech Hunter | Biotech Hunter